Infant Flow™ SiPAP
For over two decades, the Infant Flow™ nCPAP system has delivered gentle respiratory support to thousands of neonates worldwide. The system, combined with the patented variable flow generator, provides NPPV by offering nasal CPAP and Biphasic modalities. The system takes the work out of breathing, freeing precious calories to be used for growth and development.
The American Academy of Pediatrics and the European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome each recommend the early use of continuous positive airway pressure (CPAP). [5,6]
Features & Benefits
- Lowest work of breathing 
- Decrease the need of intubation by 78% 
- 40% less days on respiratory support in patients treated with BiPhasic mode 
- 47% of neonates required less oxygen compared to conventional nCPAP 
- Compliant with U.S. National Patient Safety Goal (NPSG 06.01.01) for alarm safety 
Customer Education Resources
Please note that all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative.
The Latest News From Vyaire
On June 17, 2020, the Swiss Supreme Court denied an appeal brought by imtmedical ag regarding a long-standing Swiss patent dispute concerning certain flow sensor types.Read More
CHICAGO – May 14, 2020 – Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, announced today that Vyaire has been selected by the European Commission as a supplier of priority medical equipment to help address the COVID-19 pandemic.Read More